Fuqua: Advice to Scientists

Last March, Rep. Don Fuqua (D-Fla.) startled many in the science community by announcing that he was calling it quits after 24 years in the House, all of it serving on various science-oriented committees. The chairman of the House Committee on Science and Technology for the past eight years, the 53-year-old Fuqua has decided to embark on a second career as president of the Aerospace Industries Association, a Washington-based organization representing space and defense contractors. Under his dire

Written byTabitha Powledge
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Last March, Rep. Don Fuqua (D-Fla.) startled many in the science community by announcing that he was calling it quits after 24 years in the House, all of it serving on various science-oriented committees. The chairman of the House Committee on Science and Technology for the past eight years, the 53-year-old Fuqua has decided to embark on a second career as president of the Aerospace Industries Association, a Washington-based organization representing space and defense contractors.

Under his direction, a Task Force of the full Committee in 1984 undertook a massive two-year study of national science policy. A draft of the Task Force report is due by the end of the year. At press time, Fuqua was preparing a final version of a "chairman's statement" that will accompany the report.

A native of Jacksonville, Fla., Fuqua took a B.S. in agricultural economics from the University of Florida in 1957 and served ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies